Table 1.
Characteristics | MUC20 expression (n a ) | P value b | |
---|---|---|---|
Low | High | ||
Age (years) | 0.548 | ||
≤60 | 7 | 9 | |
>60 | 15 | 30 | |
Gender | 0.173 | ||
Male | 17 | 23 | |
Female | 5 | 16 | |
Differentiated grades | 0.342 | ||
Better | 19 | 29 | |
Poor | 3 | 10 | |
Lymph node metastasis | 0.416 | ||
No | 11 | 14 | |
Yes | 11 | 25 | |
Distant metastasis | 0.588 | ||
No | 9 | 13 | |
Yes | 13 | 26 | |
AJCC stages | 0.251 | ||
Early stagec | 10 | 12 | |
Late stage | 12 | 27 | |
Local recurrence | 0.026* | ||
No | 9 | 6 | |
Yes | 13 | 33 | |
Adjuvant therapy | 0.426 | ||
No | 14 | 20 | |
Yes | 8 | 19 |
anumber of case
bChi-square test
cearly stage indicates AJCC stage IB and IIA; late stage indicates ATCC stage IIB, III, and IV
*P < 0.05